KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Amortizatization of Intangibles (2018 - 2025)

Vir Biotechnology's Amortizatization of Intangibles history spans 8 years, with the latest figure at -$1.5 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 28.55% year-over-year to -$1.5 million; the TTM value through Dec 2025 reached -$9.5 million, down 75.54%, while the annual FY2025 figure was -$9.5 million, 75.54% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was -$1.5 million at Vir Biotechnology, down from -$1.3 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $9.4 million in Q1 2023 and bottomed at -$4.1 million in Q1 2025.
  • The 5-year median for Amortizatization of Intangibles is -$381500.0 (2021), against an average of $165550.0.
  • The largest annual shift saw Amortizatization of Intangibles surged 6941.35% in 2023 before it tumbled 1618.07% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $134000.0 in 2021, then surged by 5592.54% to $7.6 million in 2022, then plummeted by 117.71% to -$1.4 million in 2023, then plummeted by 60.47% to -$2.2 million in 2024, then rose by 28.55% to -$1.5 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Amortizatization of Intangibles are -$1.5 million (Q4 2025), -$1.3 million (Q3 2025), and -$2.5 million (Q2 2025).